View Older Stories View More Recent Stories

Nov 22, 2022 08:00AM LexaGene Successfully Completes Statement of Work for BioPharma Company
Nov 1, 2022 04:01PM LexaGene Closes Secured Convertible Note Transaction
Oct 27, 2022 05:18PM LexaGene Holdings Proposes to Amend Warrants Terms
Oct 24, 2022 08:00AM LexaGene Enters into Secured Convertible Note Agreement
Oct 20, 2022 07:45AM Large Biopharma Company Engages LexaGene in Statement of Work to Expedite Technology Validation
Oct 13, 2022 07:45AM LexaGene Receives Signed Quote from Large Biopharma Company to Purchase a MiQLab System
Sep 1, 2022 08:00AM LexaGene Announces MiQLab® System Sale to Veterinary Hospital in California
Aug 29, 2022 08:00AM LexaGene Verifies CDC Monkeypox Assay Works on MiQLab System and Readies Company Should an EUA be Declared
Aug 24, 2022 08:00AM LexaGene’s MiQLab System Generates Leptospira Results in as Soon as 30 minutes using Isothermal Chemistry
Aug 17, 2022 08:00AM University of Pennsylvania’s School of Veterinary Medicine to Evaluate New Gastrointestinal Panel Using LexaGene’s MiQLab System
Aug 10, 2022 08:00AM LexaGene Reduces Time-to-Result by ~35%
Jul 29, 2022 07:58AM LexaGene Announces Filing of Financial Statements, Revocation of MCTO & the Granting of Incentive Equity Awards to Employees
Jul 27, 2022 07:58AM LexaGene Completes Multi-Center Validation Study Using MiQLab® System for Diagnosing Urinary Tract Infections
Jul 12, 2022 08:00AM LexaGene Provides MCTO Update
Jul 5, 2022 07:55AM LexaGene Announces Webinar by UC Davis Professor on Use of MiQLab® System for Diagnosis of Urinary Tract Infections
Jul 1, 2022 07:45AM LexaGene Announces MiQLab® System Sale to Veterinary Hospital in Wisconsin
Jun 30, 2022 05:32PM LexaGene Announces Management Cease Trade Order
Jun 28, 2022 06:46PM LexaGene Files Form 10 Registration Statement with the SEC and Announces a Delay in Filing Year-End Annual Canadian Financial Filings
May 25, 2022 07:45AM LexaGene Announces Multi-System Purchase from a Large Market Leader in Animal Health
May 3, 2022 08:00AM LexaGene Successfully Completes CRADA with US Army
Apr 25, 2022 08:45AM LexaGene Announces Multi-System Purchase from a Corporate Veterinary Reference Laboratory
Mar 29, 2022 07:45AM LexaGene Announces Advancements to its Sample Preparation Cartridge for the Veterinary Market
Jan 3, 2022 07:45AM LexaGene Starts the Year with Additional MiQLab Sales
Dec 17, 2021 01:08PM LexaGene Announces Results of Annual General and Special Meeting
Dec 3, 2021 07:45AM LexaGene Closes Multiple MiQLab Sales
Nov 24, 2021 04:00PM LexaGene Intends to Pursue Full Panel Pathogen Testing through the FDA
Nov 15, 2021 07:45AM Leading Veterinary Academic, Dr. Jane Sykes, Joins LexaGene Board of Directors
Nov 9, 2021 07:45AM LexaGene Expands Bio-Pharma Contamination Panel by Adding Test that includes a Biothreat Agent
Nov 2, 2021 07:45AM LexaGene Receives 2021 BioTech Breakthrough Award
Nov 1, 2021 07:45AM LexaGene Finalizes Design of Pneumonia Panel
Oct 29, 2021 07:45AM LexaGene Completes First Stage of U.S. ARMY DEVCOM Agreement
Oct 27, 2021 07:45AM LexaGene’s MiQLab™ System Selected to be a Best in Show Spotlight at the 47th Annual Industry Petcare Innovation Summit
Oct 26, 2021 10:55AM LexaGene to Host Corporate Update on November 3
Oct 25, 2021 07:45AM LexaGene Completes Analytical Studies for FDA EUA of COVID-19 Testing
Oct 7, 2021 07:45AM LexaGene’s Largest Study Validates Accuracy of its Veterinary Test Panel
Oct 6, 2021 08:32AM LexaGene to Webcast Live at VirtualInvestorConferences.com October 7th
Oct 1, 2021 07:45AM LexaGene Expands Brand Awareness at Key Investor Conferences
Sep 30, 2021 07:45AM LexaGene Reports on Recent Veterinary Trade Shows
Sep 17, 2021 04:00PM LexaGene Adopts Corporate Governance Charters and Policies
Sep 16, 2021 07:45AM LexaGene Enters into Cooperative Research and Development Agreement with the United States Army’s Combat Capabilities Development Command
Sep 7, 2021 07:45AM LexaGene’s MiQLab™ Accurately Detects Multiple Strains of Pathogenic Bacteria in Polymicrobial Samples Compared to Conventional Culture
Sep 3, 2021 07:45AM LexaGene’s MiQLab™ System Featured at Three Key Veterinary Tradeshows
Aug 12, 2021 07:45AM LexaGene Demonstrates a Simple and Inexpensive Multiplex PCR Chemistry with Shorter Lead Times for use on its MiQLab System
Jul 20, 2021 07:45AM LexaGene’s MiQLab Detects Common Bioreactor Contaminant up to 300 Times Faster than Conventional Methods
Jul 14, 2021 07:45AM LexaGene Retains Wolf Greenfield Intellectual Property Law Firm
Jul 7, 2021 07:45AM LexaGene Launches 2nd Generation Bacterial and Drug Resistance Test to Better Meet the Diagnostic Needs of Veterinarians
Jul 2, 2021 07:45AM LexaGene Advances Towards FDA Emergency Use Authorization
Jun 29, 2021 10:01AM LexaGene Announces Fourth Quarter and Full-Year End February 28, 2021, Financial Results
Jun 28, 2021 07:45AM LexaGene Engages LaVoieHealthScience as Integrated Investor and Public Relations Agency of Record
Jun 24, 2021 07:45AM New Sale of LexaGene’s MiQLab™ System Propels Early Diagnostic Testing in Veterinarian Practices
View More Recent Stories View Older Stories